Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24346154 | 0.86 | HSD17B10 (0.56) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL29745663 | 0.86 | HSD17B10 (0.56) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL17125223 | 0.86 | HSD17B10 (0.60) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL3472278 | 0.83 | HSD17B10 (0.49) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL16954413 | 0.83 | HSD17B10 (0.56) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL5804176 | 0.82 | HSD17B10 (0.51) | HSD17B10KMT2AMEN1VCAM1LMNA | |
| SCHEMBL6244176 | 0.81 | ALDH1A1 (0.55) | KMT2AMEN1LMNAALDH1A1GAA | |
| SCHEMBL7465528 | 0.81 | ALDH1A1 (0.55) | LMNAALDH1A1GAAMAPTPOLB | |
| SCHEMBL11317580 | 0.81 | ALDH1A1 (0.58) | HSD17B10KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL22866211 | 0.79 | ALDH1A1 (0.44) | LMNAALDH1A1GAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111440077-B | Synthesis method of 2, 5-diaminophenylethanol sulfate and application thereof in antiallergic hair dye | 上海舒尔发化妆品科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-111440077-A | Synthesis method of 2, 5-diaminophenylethanol sulfate and application thereof in anti-allergic hair dye | 上海舒尔发化妆品科技有限公司 | 2020-07-24 | — | — | CN | disclosed |
| US-20180044326-A1 | LACTAMS AS INHIBITORS OF ROCK | BRISTOL-MYERS SQUIBB COMAPANY (US) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044326-A1 | LACTAMS AS INHIBITORS OF ROCK | MYLK, ROCK1, RHOA | HSD17B10 3081/4885KMT2A 2627/4885MEN1 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.